Loading...
Loading...
Among the 1 tracked institutional investors we monitor, ERNAW (ERNEXA THERAPEUTICS INC) is held with a combined value of $11.41K across 160,000 shares. The largest holder is ARMISTICE CAPITAL, LLC with a position worth $11.41K. 1 fund reduced its position.
Total Institutional Value
$11.41K
Total Shares Held
160,000
Institutional Holders
1
Ranked by estimated dollars moved (share change × implied price). 13F data lags up to 45 days.
None this quarter.
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | ARMISTICE CAPITAL, LLC | $11.41K | 0.00% | -96.0% |
As of the latest SEC 13F filings, ARMISTICE CAPITAL, LLC is the largest institutional holder of ERNAW with a position worth $11.41K, representing 0.00% of their portfolio. In total, 1 institutional investors hold ERNAW with a combined value of $11.41K.
Institutional investors hold $11.41K worth of ERNAW stock across 1 positions. The largest institutional holder is ARMISTICE CAPITAL, LLC with $11.41K in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For ERNAW, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
Get notified when hedge funds change their ERNAW positions.
Last Close
$0.05
2026-08-18
YTD
-50.0%
18% of 52-week range